ATE511517T1 - Vom cd4-rezeptor abgeleitete peptide und verfahren zur herstellung davon - Google Patents

Vom cd4-rezeptor abgeleitete peptide und verfahren zur herstellung davon

Info

Publication number
ATE511517T1
ATE511517T1 AT07802491T AT07802491T ATE511517T1 AT E511517 T1 ATE511517 T1 AT E511517T1 AT 07802491 T AT07802491 T AT 07802491T AT 07802491 T AT07802491 T AT 07802491T AT E511517 T1 ATE511517 T1 AT E511517T1
Authority
AT
Austria
Prior art keywords
receptor
relates
production
peptides derived
derived
Prior art date
Application number
AT07802491T
Other languages
English (en)
Inventor
Francoise Baleux
David Bonnaffe
Hugues Lortat-Jacob
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE511517T1 publication Critical patent/ATE511517T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT07802491T 2006-08-04 2007-08-03 Vom cd4-rezeptor abgeleitete peptide und verfahren zur herstellung davon ATE511517T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0607149A FR2904627B1 (fr) 2006-08-04 2006-08-04 Nouveaux peptides actives, purifies et isoles, derives du recepteur cd4 (mini-cd4) et leur procece de preparation
PCT/EP2007/058069 WO2008015273A1 (fr) 2006-08-04 2007-08-03 Peptides derives du recepteur cd4 et leur procede de preparation

Publications (1)

Publication Number Publication Date
ATE511517T1 true ATE511517T1 (de) 2011-06-15

Family

ID=37704295

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07802491T ATE511517T1 (de) 2006-08-04 2007-08-03 Vom cd4-rezeptor abgeleitete peptide und verfahren zur herstellung davon

Country Status (11)

Country Link
US (1) US20110015368A1 (de)
EP (1) EP2054439B1 (de)
JP (1) JP5479095B2 (de)
CN (1) CN101516909A (de)
AT (1) ATE511517T1 (de)
AU (1) AU2007280351A1 (de)
CA (1) CA2659149C (de)
ES (1) ES2367400T3 (de)
FR (1) FR2904627B1 (de)
WO (1) WO2008015273A1 (de)
ZA (1) ZA200900816B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087911A1 (de) * 2008-02-06 2009-08-12 Institut Pasteur Konjugierte Moleküle mit einem Peptid aus dem mit einem Polyanion gekoppelten CD4-Rezeptor zur Behandlung von AIDS
EP2505210A1 (de) 2011-03-18 2012-10-03 Institut Pasteur Konjugierte Moleküle mit einem Peptid aus dem an ein polyanionischen Polypeptids gekoppelten CD4-Rezeptor zur Behandlung von AIDS
CN102321653B (zh) * 2011-07-18 2013-11-20 清华大学 人鼠嵌合型cd4质粒及其多抗在抑制hiv感染中的应用
WO2015042860A1 (en) * 2013-09-27 2015-04-02 Intel Corporation Mechanism for facilitating dynamic and proactive data management for computing devices
EA201700177A1 (ru) * 2014-10-09 2017-07-31 Мсд Уэлком Траст Хиллеман Лабораторис Пвт. Лтд. Улучшенный способ конъюгирования и полученные с помощью него новые синтетические конъюгаты олигосахарида с белком
EP3220957B1 (de) * 2014-10-24 2018-11-07 Institut Pasteur Konjugierte moleküle mit einem peptid aus dem an ein anionisches polypeptid gekoppelten cd4-rezeptor zur behandlung von aids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819809B1 (fr) * 2001-01-23 2003-05-16 Commissariat Energie Atomique Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides
WO2005003296A2 (en) * 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
FR2841250B1 (fr) * 2002-06-19 2004-07-23 Commissariat Energie Atomique Composes se liant a l'interferon-gamma, leur procede de preparation, et medicaments les contenant
ATE461217T1 (de) * 2003-12-18 2010-04-15 Novo Nordisk As Glp-1-verbindungen
US7604804B2 (en) * 2004-02-09 2009-10-20 University Of Maryland Biotechnology Institute Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
US20050260153A1 (en) * 2004-04-13 2005-11-24 Pericles Calias Facilitation of iontophoresis using charged moieties
WO2007144685A1 (en) * 2006-06-13 2007-12-21 Commissariat A L'energie Atomique Cd4 mimic peptides and their uses
EP2087911A1 (de) * 2008-02-06 2009-08-12 Institut Pasteur Konjugierte Moleküle mit einem Peptid aus dem mit einem Polyanion gekoppelten CD4-Rezeptor zur Behandlung von AIDS

Also Published As

Publication number Publication date
JP5479095B2 (ja) 2014-04-23
ZA200900816B (en) 2009-12-30
CN101516909A (zh) 2009-08-26
CA2659149C (fr) 2015-11-24
EP2054439B1 (de) 2011-06-01
CA2659149A1 (fr) 2008-02-07
FR2904627B1 (fr) 2008-11-07
AU2007280351A1 (en) 2008-02-07
EP2054439A1 (de) 2009-05-06
WO2008015273A8 (fr) 2008-03-27
US20110015368A1 (en) 2011-01-20
WO2008015273A1 (fr) 2008-02-07
JP2009545626A (ja) 2009-12-24
FR2904627A1 (fr) 2008-02-08
ES2367400T3 (es) 2011-11-03

Similar Documents

Publication Publication Date Title
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
EA201170040A1 (ru) Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и способы их получения и применения
PE20081171A1 (es) Nuevos anticuerpos anti-cd38 para el tratamiento del cancer
CY1117331T1 (el) Αντισωματα προσδεσης στην εξωκυτταρικη περιοχη 4 του ανθρωπινου csf1r και η χρηση αυτων
ATE511517T1 (de) Vom cd4-rezeptor abgeleitete peptide und verfahren zur herstellung davon
MX342643B (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
PE20121393A1 (es) Analogo peptidico de oxintomodulina
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
WO2011143201A3 (en) Ratiometric combinatorial drug delivery
MX2013000958A (es) Fabricación del inhibidor-inter-alfa (iaip) a partir de plasma.
ATE512677T1 (de) Verfahren und geräte zur herstellung von kunststoffen auf plasmabasis und daraus hergestellte biologische kunststoffe
ATE544566T1 (de) Verfahren zur herstellung von dünne metallnanodrähte durch biotemplating
WO2009150547A3 (en) 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors
GB2496342A (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
GEP20115293B (en) Isolated extract of walnuts, process for its obtaining and its use
WO2010132370A3 (en) Soluble tlt-1 for the treatment and diagnosis of sepsis
UA107836C2 (uk) Метод лікування хвороби альцгеймера
CL2007003754A1 (es) Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc.
WO2010135521A3 (en) Compositions and methods for the therapy and diagnosis of influenza
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
WO2009138494A3 (en) Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors
WO2008028934A8 (en) Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
WO2010040736A3 (en) Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling
WO2011064779A3 (en) Peptides derived from hiv-1 gp41 transmembrane for t - immunomodulation
WO2009098147A3 (en) Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties